- Home
- RGT vs FORA Comparison
RGT vs FORA Comparison
Compare RGT & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGT | FORA |
|---|---|---|
| Founded | 1986 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.2M | 69.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RGT | FORA |
|---|---|---|
| Price | $13.17 | $2.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.4K | ★ 29.7K |
| Earning Date | 01-01-0001 | 11-14-2025 |
| Dividend Yield | ★ 1.43% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | N/A | ★ $28,106,911.00 |
| Revenue This Year | N/A | $47.82 |
| Revenue Next Year | N/A | $10.11 |
| P/E Ratio | $11.42 | ★ N/A |
| Revenue Growth | N/A | ★ 37.47 |
| 52 Week Low | $7.84 | $1.64 |
| 52 Week High | $11.08 | $4.03 |
Technical Indicators
Market Signals| Indicator | RGT | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 65.00 | 51.24 |
| Support Level | $12.93 | $2.06 |
| Resistance Level | $13.23 | $2.12 |
| Average True Range (ATR) | 0.14 | 0.04 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 88.25 | 71.48 |
Price Performance
Historical ComparisonAbout RGT Royce Global Value Trust Inc.
Royce Global Value Trust Inc is a diversified closed-end investment company. The fund spreads its investments across diversified sectors such as information technology, consumer discretionary, health care, materials, consumer staples, and energy. Geographically, it has presence in the region of the United Kingdom, Japan, the United States, Canada, France, Hong Kong, and Germany.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.